2tcl
|
STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
OverviewOverview
In rheumatoid and osteoarthritis, degradation of articular cartilage is, mediated by the matrix metalloproteinases collagenase, stromelysin and, gelatinase. The key event in this process is the cleavage of triple, helical collagen by collagenase. We have determined the crystal structure, of the catalytic domain of human recombinant fibroblast collagenase, complexed with a synthetic inhibitor at 2.2 A resolution. The protein fold, is similar to the amino termini of the zinc endopeptidases astacin, thermolysin and elastase despite a lack of primary sequence homology. The, conformation of the bound inhibitor provides a molecular basis for the, design of inhibitors of collagenase and other matrix metalloproteinases., Such inhibitors should be useful in the treatment of a variety of diseases, including arthritis and cancer.
DiseaseDisease
Known diseases associated with this structure: COPD, rate of decline of lung function in OMIM:[120353]
About this StructureAbout this Structure
2TCL is a Single protein structure of sequence from Homo sapiens with ZN, SM, CA and RO4 as ligands. Full crystallographic information is available from OCA.
ReferenceReference
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor., Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ, Nat Struct Biol. 1994 Feb;1(2):106-10. PMID:7656013
Page seeded by OCA on Mon Nov 12 23:38:24 2007